ÂÜÀòÂÒÂ×

Jürgen Langhärig holds a Doctor’s Degree in Biotechnology from the University of Tübingen/Germany an executive MBA from the University of St. Gallen/Switzerland. He is a well-respected name in pharma and biotech Business Development community with over 40 years of experience.

He held business development and managerial positions at Evaxion Biotech A/S (until March 2022), Serodus ASA, Bavarian Nordic A/S, Zealand Pharma A/S, Novo Nordisk A/S, Nycomed Pharma (now Takeda) and Sandoz AG (now Novartis).